A trial to study the effects of prophylactic use of Tranexamic acid in reducing blood loss after normal vaginal delivery
Phase 3
- Registration Number
- CTRI/2017/07/009011
- Lead Sponsor
- AFMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 273
Inclusion Criteria
Age > 20 yrs
Term pregnancies >37 wks
Singleton pregnancies
Planned vaginal deliveries
Exclusion Criteria
Age <19 and >35 yrs
Pre eclampsia,multiple pregnancy,placental abnormalities
Instrumental deliveries
Any cardiovascular, renal, liver disorders
Any hematological , hemorrhagic disorders
H/o venous or arterial thrombosis
H/o use of LMWH or antiplatelet drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean change in peripartum hemoglobin and hematocrit values in the two groups <br/ ><br>Timepoint: After 24 hrs of Delivery
- Secondary Outcome Measures
Name Time Method â?¢Requirement of use of additional uterotonic agents to control blood loss in the two groupsTimepoint: Within 24 hrs;To compare the incidence of PPH in control and test armTimepoint: Within first 6 hrs